
Benny Quoc Tieu
Supervisory Patent Examiner (ID: 2443, Phone: (571)272-7490 , Office: P/2674 )
| Most Active Art Unit | 2642 |
| Art Unit(s) | 2614, 2642, 2625, 2742, 2674, 2682 |
| Total Applications | 759 |
| Issued Applications | 578 |
| Pending Applications | 87 |
| Abandoned Applications | 103 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16883863
[patent_doc_number] => 20210170058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => MODIFIED ANTIBODY AND RADIOACTIVE METAL-LABELLED ANTIBODY
[patent_app_type] => utility
[patent_app_number] => 17/047859
[patent_app_country] => US
[patent_app_date] => 2019-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10865
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17047859
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/047859 | Modified antibody and radioactive metal-labelled antibody | Apr 14, 2019 | Issued |
Array
(
[id] => 16824239
[patent_doc_number] => 20210139532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => PEPTIDE SYNTHESIS METHOD
[patent_app_type] => utility
[patent_app_number] => 17/046682
[patent_app_country] => US
[patent_app_date] => 2019-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24830
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 283
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17046682
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/046682 | Peptide synthesis method | Apr 12, 2019 | Issued |
Array
(
[id] => 16817010
[patent_doc_number] => 11001817
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-11
[patent_title] => Delivery of cargo proteins via ARRDC1-mediated microvesicles (ARMMs)
[patent_app_type] => utility
[patent_app_number] => 16/382927
[patent_app_country] => US
[patent_app_date] => 2019-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 29785
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16382927
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/382927 | Delivery of cargo proteins via ARRDC1-mediated microvesicles (ARMMs) | Apr 11, 2019 | Issued |
Array
(
[id] => 17241994
[patent_doc_number] => 20210361737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => ANTI-INFECTIVE FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/046271
[patent_app_country] => US
[patent_app_date] => 2019-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37610
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -139
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17046271
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/046271 | Anti-infective formulations | Apr 10, 2019 | Issued |
Array
(
[id] => 16915830
[patent_doc_number] => 20210188922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => COMPOSITIONS, METHODS, AND SYSTEMS FOR ORALLY ADMINISTRABLE AFFINITY-BASED PROTEIN
[patent_app_type] => utility
[patent_app_number] => 17/041780
[patent_app_country] => US
[patent_app_date] => 2019-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5282
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17041780
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/041780 | Compositions, methods, and systems for orally administrable affinity-based protein | Mar 24, 2019 | Issued |
Array
(
[id] => 16539407
[patent_doc_number] => 20200405820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => PARATHYROID HORMONE POLYPEPTIDE CONJUGATES AND METHODS OF THEIR USE
[patent_app_type] => utility
[patent_app_number] => 16/980944
[patent_app_country] => US
[patent_app_date] => 2019-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11727
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16980944
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/980944 | Parathyroid hormone polypeptide conjugates and methods of their use | Mar 14, 2019 | Issued |
Array
(
[id] => 16605945
[patent_doc_number] => 10906937
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-02
[patent_title] => Peptides and compositions comprising same and uses thereof in the treatment of diseases
[patent_app_type] => utility
[patent_app_number] => 16/299206
[patent_app_country] => US
[patent_app_date] => 2019-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 26
[patent_no_of_words] => 12864
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16299206
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/299206 | Peptides and compositions comprising same and uses thereof in the treatment of diseases | Mar 11, 2019 | Issued |
Array
(
[id] => 16621506
[patent_doc_number] => 20210040159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => CPG AMPHIPHILES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/977185
[patent_app_country] => US
[patent_app_date] => 2019-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4298
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16977185
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/977185 | CpG amphiphiles and uses thereof | Feb 28, 2019 | Issued |
Array
(
[id] => 19456322
[patent_doc_number] => 12096785
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-24
[patent_title] => Lipid emulsion nutritional product
[patent_app_type] => utility
[patent_app_number] => 16/971055
[patent_app_country] => US
[patent_app_date] => 2019-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 6392
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16971055
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/971055 | Lipid emulsion nutritional product | Feb 18, 2019 | Issued |
Array
(
[id] => 14534525
[patent_doc_number] => 20190202884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => MODIFIED GLUCAGON MOLECULES
[patent_app_type] => utility
[patent_app_number] => 16/278851
[patent_app_country] => US
[patent_app_date] => 2019-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9471
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16278851
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/278851 | Modified glucagon molecules | Feb 18, 2019 | Issued |
Array
(
[id] => 14744019
[patent_doc_number] => 20190255183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => CNP PRODRUGS
[patent_app_type] => utility
[patent_app_number] => 16/269097
[patent_app_country] => US
[patent_app_date] => 2019-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38261
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16269097
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/269097 | CNP PRODRUGS | Feb 5, 2019 | Abandoned |
Array
(
[id] => 16892077
[patent_doc_number] => 11033604
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-15
[patent_title] => Reagents and methods for treating bacterial infection
[patent_app_type] => utility
[patent_app_number] => 16/258505
[patent_app_country] => US
[patent_app_date] => 2019-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 12586
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16258505
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/258505 | Reagents and methods for treating bacterial infection | Jan 24, 2019 | Issued |
Array
(
[id] => 14566911
[patent_doc_number] => 20190211062
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => Modified Proteins and Methods of Use Thereof
[patent_app_type] => utility
[patent_app_number] => 16/250213
[patent_app_country] => US
[patent_app_date] => 2019-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41507
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16250213
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/250213 | Modified proteins and methods of use thereof | Jan 16, 2019 | Issued |
Array
(
[id] => 15267421
[patent_doc_number] => 20190382444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => Zinc-binder Based EBNA1-Specific Compounds
[patent_app_type] => utility
[patent_app_number] => 16/249987
[patent_app_country] => US
[patent_app_date] => 2019-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17721
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16249987
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/249987 | Zinc-binder based EBNA1-specific compounds | Jan 16, 2019 | Issued |
Array
(
[id] => 16168220
[patent_doc_number] => 10709760
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-14
[patent_title] => Treatment of chronic ulcers
[patent_app_type] => utility
[patent_app_number] => 16/245642
[patent_app_country] => US
[patent_app_date] => 2019-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6797
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16245642
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/245642 | Treatment of chronic ulcers | Jan 10, 2019 | Issued |
Array
(
[id] => 17844911
[patent_doc_number] => 11434263
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-06
[patent_title] => Stabilized polypeptides and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/955557
[patent_app_country] => US
[patent_app_date] => 2019-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 11603
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 215
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16955557
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/955557 | Stabilized polypeptides and uses thereof | Jan 3, 2019 | Issued |
Array
(
[id] => 16686810
[patent_doc_number] => 20210069285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => COMPOSITIONS AND METHODS OF TREATING CANCER WITH GLYCOMIMETIC PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 16/960267
[patent_app_country] => US
[patent_app_date] => 2019-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20900
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16960267
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/960267 | Compositions and methods of treating cancer with glycomimetic peptides | Jan 2, 2019 | Issued |
Array
(
[id] => 14403833
[patent_doc_number] => 20190167760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => POLYPEPTIDES BINDING TO HUMAN COMPLEMENT C5
[patent_app_type] => utility
[patent_app_number] => 16/228181
[patent_app_country] => US
[patent_app_date] => 2018-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23067
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -89
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16228181
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/228181 | Polypeptides binding to human complement C5 | Dec 19, 2018 | Issued |
Array
(
[id] => 18070605
[patent_doc_number] => 11529421
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-20
[patent_title] => Modified globin proteins
[patent_app_type] => utility
[patent_app_number] => 15/733287
[patent_app_country] => US
[patent_app_date] => 2018-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 18
[patent_no_of_words] => 20692
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15733287
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/733287 | Modified globin proteins | Dec 18, 2018 | Issued |
Array
(
[id] => 14277177
[patent_doc_number] => 20190135873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING DISEASES BY INHIBITING EXOSOME RELEASE
[patent_app_type] => utility
[patent_app_number] => 16/226283
[patent_app_country] => US
[patent_app_date] => 2018-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23977
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16226283
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/226283 | Compositions and methods for treating diseases by inhibiting exosome release | Dec 18, 2018 | Issued |